Evidence map›Paper›PMID 35349303›Full record

ArticleScience signaling2022

Palmitoylation couples the kinases DLK and JNK3 to facilitate prodegenerative axon-to-soma signaling.

Jingwen Niu, Sabrina M Holland, Andrea Ketschek, Kaitlin M Collura, Natasha L Hesketh, Takashi Hayashi, Gianluca Gallo, Gareth M Thomas

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Remyelination protects neurons from DLK-mediated neurodegeneration.bioRxiv : the preprint server for biology · 2024
    Article
  15. Review
  16. NADAntioxidants & redox signaling · 2023
    Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jingwen NiuShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0001-5456-1485
Sabrina M HollandShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0003-4805-1803
Andrea KetschekShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0002-1863-0436
Kaitlin M ColluraShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0003-2260-2849
Natasha L HeskethShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0003-4633-9010
Takashi HayashiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Central6 (6-10), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.ORCID 0000-0003-3591-2109
Gianluca GalloShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.
Gareth M ThomasShriners Hospitals Pediatric Research Center (Center for Neurorehabilitation and Neural Repair), Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA.ORCID 0000-0003-3183-8431
Temple University Hospital · USNational Institute of Advanced Industrial Science and Technology · JP

Funding

Regulation of Axonal Signaling by PalmitoylationR01NS094402 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI THOMAS, GARETH · 2015 to 2025
$3.7M
Palmitoylation-dependent Control of Glaucomatous NeurodegenerationR21EY029386 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI THOMAS, GARETH · 2019 to 2020
$454k
NEI NIH HHS R21 EY029386NINDS NIH HHS R01 NS094402
6 · The paper itself

Abstract

Dual leucine-zipper kinase (DLK; a MAP3K) mediates neuronal responses to diverse injuries and insults through the c-Jun N-terminal kinase (JNK) family of mitogen-activated protein kinases (MAPKs). Here, we identified two ways through which DLK is coupled to the neural-specific isoform JNK3 to control prodegenerative signaling. JNK3 catalyzed positive feedback phosphorylation of DLK that further activated DLK and locked the DLK-JNK3 module in a highly active state. Neither homologous MAP3Ks nor a homologous MAPK could support this positive feedback loop. Unlike the related JNK1 isoform JNK2 and JNK3 promote prodegenerative axon-to-soma signaling and were endogenously palmitoylated. Moreover, palmitoylation targeted both DLK and JNK3 to the same axonal vesicles, and JNK3 palmitoylation was essential for axonal retrograde signaling in response to optic nerve crush injury in vivo. These findings provide previously unappreciated insights into DLK-JNK signaling relevant to neuropathological conditions and answer long-standing questions regarding the selective prodegenerative roles of JNK2 and JNK3.

Indexed as

AxonsLipoylationJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase KinasesNeuronsSignal TransductionJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase Kinases

Identifiers

PMID35349303
PMCPMC12049159
OpenAlexW4221089271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.